Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...
A trial evaluated the short-term oncologic efficacy of cooled focal therapy ablation using the ProFocal device in men with localized, intermediate-risk prostate cancer.
In today’s fast-paced world, men often face health challenges that significantly affect their quality of life. One common issue that many men experience is related to prostate health, leading to ...
Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to print (Opens in new window) Prostate cancer ...
Nocturia, a condition characterized by waking up multiple times during the night to use the bathroom, occurs in about one-third of men over the age of 30. As they age, men become even more likely to ...
A new study in Austria has shown that a special ultrasound treatment can effectively control early prostate cancer while ...
A plant-based diet combined with probiotics reduces PSA increase in men and lowers prostate cancer risk by 3x.
November 5, 2009 (Chicago, Illinois) — Anticoagulants are indicated for the treatment of cardiovascular disease but might have a role to play in prostate cancer. Anticoagulants, including aspirin, ...
Waltham — April 10, 2024 — For patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) ...
For patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) levels, compared to hormonal ...
- ATNM-400 targets a highly differentiated, non-PSMA antigen associated with the development and progression of prostate cancer, exhibiting potent therapeutic activity independent of PSMA expression ...
Please provide your email address to receive an email when new articles are posted on . The steam-based treatment offers a less invasive option to patients with intermediate-risk prostate cancer. A ...